Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNA-binding motif protein 14 (RBM14) is a nuclear RNA-binding protein that possesses two RNA recognition motifs and multiple C-terminal hexapeptide repeats. It acts as a transcriptional coactivator and alternative splicing regulator, modulating nuclear hormone receptor activity and gene expression. RBM14 plays important roles in DNA damage response, especially in recruiting repair factors to double-strand break (DSB) sites and facilitating non-homologous end joining (NHEJ). It is also involved in the regulation of pre-mRNA splicing, mitotic spindle assembly, and the innate immune response via the cGAS-STING pathway. Dysregulation of RBM14 has been implicated in cancer progression (e.g., glioblastoma, osteosarcoma), cellular radioresistance, and certain neurodegenerative and ocular diseases[1][2][4][5][7].
Not established for specific drugs as of the current evidence. Small molecules or oligonucleotides modifying RNA-binding or splicing may be conceptually possible, but no specific RBM14-targeted agents are described as of now.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA-binding motif protein 14 (RBM14).